ATXS
Price
$6.64
Change
-$0.50 (-7.00%)
Updated
Mar 13 closing price
Capitalization
374.72M
55 days until earnings call
TSVT
Price
$4.96
Change
+$0.01 (+0.20%)
Updated
Mar 14, 11:30 AM (EDT)
Capitalization
258.88M
11 days until earnings call
Ad is loading...

ATXS vs TSVT

Header iconATXS vs TSVT Comparison
Open Charts ATXS vs TSVTBanner chart's image
Astria Therapeutics
Price$6.64
Change-$0.50 (-7.00%)
Volume$218.16K
Capitalization374.72M
2seventy bio
Price$4.96
Change+$0.01 (+0.20%)
Volume$100
Capitalization258.88M
ATXS vs TSVT Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. TSVT commentary
Mar 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and TSVT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 14, 2025
Stock price -- (ATXS: $6.64 vs. TSVT: $4.95)
Brand notoriety: ATXS and TSVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 80% vs. TSVT: 172%
Market capitalization -- ATXS: $374.72M vs. TSVT: $258.88M
ATXS [@Biotechnology] is valued at $374.72M. TSVT’s [@Biotechnology] market capitalization is $258.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $329.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileTSVT’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • TSVT’s FA Score: 1 green, 4 red.
According to our system of comparison, TSVT is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while TSVT’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 4 bearish.
  • TSVT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TSVT is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +3.43% price change this week, while TSVT (@Biotechnology) price change was +73.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.60%. For the same industry, the average monthly price growth was -6.51%, and the average quarterly price growth was -9.04%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

TSVT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-2.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($375M) has a higher market cap than TSVT($259M). TSVT YTD gains are higher at: 68.367 vs. ATXS (-25.727). ATXS has higher annual earnings (EBITDA): -100.97M vs. TSVT (-133.86M). ATXS has more cash in the bank: 344M vs. TSVT (192M). ATXS has less debt than TSVT: ATXS (5.64M) vs TSVT (247M). TSVT has higher revenues than ATXS: TSVT (45.6M) vs ATXS (0).
ATXSTSVTATXS / TSVT
Capitalization375M259M145%
EBITDA-100.97M-133.86M75%
Gain YTD-25.72768.367-38%
P/E RatioN/AN/A-
Revenue045.6M-
Total Cash344M192M179%
Total Debt5.64M247M2%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSTSVT
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EFCAX19.20N/A
N/A
Emerald Insights A
LMREX29.64N/A
N/A
ClearBridge Mid Cap R
MMSIX11.03N/A
N/A
Praxis Small Cap Index I
YCGEX30.79N/A
N/A
YCG Enhanced
HHHTX17.28N/A
N/A
Hartford Schroders Emerging Mkts Eq R5

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-7.00%
KYMR - ATXS
48%
Loosely correlated
-4.70%
DNLI - ATXS
47%
Loosely correlated
-6.65%
CRNX - ATXS
46%
Loosely correlated
-1.02%
ABOS - ATXS
45%
Loosely correlated
-4.69%
IMNM - ATXS
45%
Loosely correlated
-3.04%
More